Last reviewed · How we verify

NCT04742478: ROVUS

ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)

Recruiting now Last updated 23 April 2021
What this trial tests

trial testing Rotational Atherectomy in Coronary Artery Calcification in 1,000 participants. Currently enrolling.

Timeline
10 March 2021
Primary endpoint
29 February 2024
31 December 2026

Quick facts

Lead sponsorNational Heart Centre Singapore
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,000
Start date10 March 2021
Primary completion29 February 2024
Estimated completion31 December 2026
Sites2 locations across Singapore, Japan

Drugs / interventions tested

Conditions studied

Sponsor

National Heart Centre Singapore — full company profile →

Who can join

21 and older, any sex, with Coronary Artery Calcification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rotablation with or without other calcium debulking therapies is a safe adjunctive procedure for patients with severe coronary calcification requiring Percutaneous Coronary Intervention (PCI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Rotational Atherectomy

Trials testing the same drug.

Other recruiting trials for Coronary Artery Calcification

Currently open trials in the same condition.

Other National Heart Centre Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04742478.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing